Skip to main content
Log in

Prediction of LT4 Replacement Dose to Achieve Euthyroidism in Subjects Undergoing Total Thyroidectomy for Benign Thyroid Disorders

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Total thyroidectomy is becoming the preferred choice of treatment in patients with benign disorders of the thyroid gland; hence, an optimal method of replacing thyroxine is essential to avoid the ill effects of over- and under-replacement of thyroxine in such patients.

Patients and methods

We analyzed three methods of thyroxine replacement: replacement per kilogram of lean body mass (LBM) (2.5 mcg/kg LBM per day), per kilogram of body weight (1.6 mcg/kg body weight per day), and empirical replacement of thyroxine.

Results

The thyroxine requirement in thyroidectomized patients was 2.04 mcg/kg per day, with an increasing requirement of thyroxine with increments of weight. On multivariate analysis we found that the thyroxine requirement was strongly correlated both with body surface area (BSA) and with body weight. On subsequent correlation testing, we found that BSA was more strongly associated than weight with the thyroxine requirement.

Conclusions

Patients undergoing total thyroidectomy may require higher doses of thyroxine to achieve euthyroidism when compared to patients with similar anthropometric parameters having primary hypothyroidism. The method of replacing thyroxine based on LBM is the ideal method, but replacement based on fixed-dose regimens could be a good method if the body weight is taken into consideration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Banovac K, Carrington SA, Levis S et al (1990) Determination of replacement and suppressive doses of thyroxine. J Int Med Res 18:210–218

    CAS  PubMed  Google Scholar 

  2. Wiersinga WM (2001) Thyroid hormone replacement therapy. Horm Res 56(Suppl 1):74–81

    Article  CAS  PubMed  Google Scholar 

  3. Reev TS, Delbridge L, Cohen A et al (1987) Total thyroidectomy: the preferred option for multinodular goiters. Ann Surg 206:782–786

    Article  Google Scholar 

  4. Serter R, Demirbas B, Korukluoglu B et al (2004) The effect of l-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J Endocrinol Invest 27:897–903

    CAS  PubMed  Google Scholar 

  5. Fadeyev VV, Sytch J, Kalashnikov V et al (2006) Levothyroxine replacement therapy in patients with subclinical hypothyroidism and coronary artery disease. Endocr Pract 12:5–17

    PubMed  Google Scholar 

  6. Erbil Y, Ozbey N, Giriåÿ M et al (2007) Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy. Br J Surg 94:1485–1490

    Article  CAS  PubMed  Google Scholar 

  7. Weetman AP (1991) Thyroid associated eye disease: pathophysiology. Lancet 338:25–28

    Article  CAS  PubMed  Google Scholar 

  8. Kim DD, Young S, Cutfield R (2008) A survey of thyroid function test abnormalities in patients presenting with atrial fibrillation and flutter to a New Zealand district hospital. N Z Med J 71:82–86

    Google Scholar 

  9. van de Ven AC, Erdtsieck RJ (2008) Changes of bone mineral density, quantitative ultrasound parameters and markers of bone turnover during treatment of hyperthyroidism. Neth J Med 66:428–432

    PubMed  Google Scholar 

  10. Walsh JP, Bremner AP, Bulsara MK et al (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467–2472

    Article  PubMed  Google Scholar 

  11. Ombuwale O, Chadwick DR (2006) Optimization of thyroxine replacement therapy after total or near total thyroidectomy for benign thyroid disease. Br J Surg 93:57–60

    Article  Google Scholar 

  12. Sartorio A, Ferrero S, Trecate L et al (2002) Thyroid function is more strongly associated with body impedance than anthropometry in healthy subjects. J Endocrinol Invest 25:620–623

    CAS  PubMed  Google Scholar 

  13. Bolanowski M, Nilsson BE (2001) Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Med Sci Monit 7:1029–1033

    CAS  PubMed  Google Scholar 

  14. Cunningham JJ, Barzel US (1984) Lean body mass is a predictor of the daily requirement for thyroid hormone in older men and women. J Am Geriatr Soc 32:204–207

    CAS  PubMed  Google Scholar 

  15. Dickey RA, Wartofsky L, Feld S (2005) Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid 15:1035–1039

    Article  CAS  PubMed  Google Scholar 

  16. Hodges S, O’Malley BP, Northover BN et al (1990) Reappraisal of thyroxine treatment in primary hypothyroidism. Arch Dis Child 65:1129–1132

    Article  CAS  PubMed  Google Scholar 

  17. Rosenbaum RL, Barzel US (1982) Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med 96:53–55

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amit Agarwal.

Additional information

Ranjith Sukumar and Amit Agarwal contributed equally to this research.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sukumar, R., Agarwal, A., Gupta, S. et al. Prediction of LT4 Replacement Dose to Achieve Euthyroidism in Subjects Undergoing Total Thyroidectomy for Benign Thyroid Disorders. World J Surg 34, 527–531 (2010). https://doi.org/10.1007/s00268-009-0345-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-009-0345-3

Keywords

Navigation